Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to evaluate the comparative efficacy of Lamictal
(lamotrigine) to placebo in neurotic excoriation. Thirty subjects with neurotic excoriation
will receive 12 weeks of double-blind treatment with Lamictal (lamotrigine) or matching
placebo. The hypothesis to be tested is that Lamictal (lamotrigine) will be more effective
than placebo in patients with neurotic excoriation. The proposed study will provide needed
data on the treatment of a disabling disorder that currently lacks a clearly effective
treatment.